Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05238636Unknown

Gastro-intestinal Physiology After Anti-Reflux Procedures

Role: collaborator

NCT04810234Unknown

Neural Correlates of tVNS

Role: collaborator

NCT02360384Not ApplicableUnknown

Caecal pH as a Biomarker for Irritable Bowel Syndrome

Role: lead

NCT02620176Not ApplicableUnknown

The Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Oesophageal Pain Hypersensitivity

Role: lead

NCT02177890Not ApplicableCompleted

Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers

Role: lead

All 5 trials loaded